Scott Gawlik, DPM
Podiatrist · Brooklyn, NYNPI 1043246085
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 77.3% of it on its own, with 34 other manufacturers making up the rest. 2025 is the largest year on record at $25,327, more than ten times the $1,651 reported in 2019. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $265.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$59K
- Stryker$9K
- Smith+Nephew$3K
- Abbott$573
- Treace Medical Concepts, Inc.$547
- Tactile Systems Technology Inc$527
- plus $4K from 29 others
What the payments were for
- Consulting fees$6,3508%
- Speaking & faculty fees$41,25054%
- Travel & lodging$7,52510%
- Food & beverage$19,79526%
- Education$1,8002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 62 | $59,320 |
| Stryker(2 entities) | 34 | $9,006 |
| Smith+Nephew | 66 | $2,559 |
| Abbott | 4 | $573 |
| Treace Medical Concepts, Inc. | 10 | $547 |
| Tactile Systems Technology Inc | 23 | $527 |
| Integra Lifesciences Corporation | 12 | $407 |
| Inari Medical, Inc. | 2 | $378 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $350 |
| Baxter Healthcare | 3 | $323 |
| Nevro Corp. | 5 | $240 |
| Bioventus LLC | 8 | $225 |
| Orthofix Medical, Inc. | 4 | $221 |
| Paratek Pharmaceuticals, Inc. | 5 | $201 |
| Solventum Corporation | 5 | $192 |
| Zimmer Biomet | 4 | $189 |
| Paragon 28, Inc. | 3 | $188 |
| Organogenesis Inc. | 3 | $184 |
| DJO, LLC | 3 | $167 |
| KCI USA, Inc. | 5 | $132 |
| Misonix Inc | 3 | $124 |
| Nalu Medical, Inc. | 1 | $122 |
| Medtronic | 1 | $106 |
| Osteomed LLC | 3 | $81 |
| Averitas Pharma Inc. | 4 | $71 |
| Sandoz | 2 | $47 |
| Derma Sciences, Inc. | 2 | $45 |
| Vertex | 2 | $38 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $35 |
| Convatec Inc. | 2 | $31 |
| Polynovo North America LLC | 1 | $24 |
| Next Science LLC | 1 | $20 |
| Biocomposites Inc | 1 | $19 |
| Amgen | 1 | $16 |
| Sanara Medtech Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$100,942
- Kerecis Omega3 SurgiClose$81,266
- Kerecis SurgiClose$67,920
- Kerecis Omega3 GraftGuide$24,495
- Kerecis GraftGuide$16,980
- CT THROMBECTOMY SYSTEM KIT$6,214
- FLOWTRIEVER CATHETER, S$3,920
- Stravix$868
- HOFFMANN$738
- CITREFIX$605
- Supera peripheral stent system$573
- ALLOWRAP$546
- FLEXBAND$443
- AUGMENT INJECTABLE$430
- AUGMENT$387
- 7 X 23MM CITRELOCK IMPLANT$361
- VARIAX$354
- Ketodan$350
- Neo-Synalar$350
- Tovet (emollient formulation)$350
How this compares
$76,720 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 30 | $14,667 |
| Mupirocin | 71 | $506 |
| Diclofenac Sodium | 37 | $397 |
| CiclopiroxCiclopirox Olamine | 20 | $382 |
| Ammonium Lactate | 13 | $350 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $319 |
| Ciclopirox | 11 | $253 |
| Terbinafine Hcl | 32 | $239 |
| Cefadroxil | 17 | $114 |
| Doxycycline Hyclate | 13 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $2,559 | $14,66730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 862 podiatrist providers in New York.
Other podiatrist in Brooklyn
- Rupinder BooraBrooklyn$10K
- Kevin JeongBrooklyn$10K
- Christopher BromleyPoughkeepsie$152K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
- Jude ViolanteNiagara Falls$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.